with first data readout expected in summer 2025 European Committee for Medicinal Products for Human Use (CHMP) review of ...

In a report released on November 7, Joseph Schwartz from Leerink Partners reiterated a Buy rating on Applied Therapeutics (APLT – ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

and in the first European countries for second-line ESCC and first- and second-line non-small cell lung cancer (NSCLC); ...

NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November ...

In the United States, highly purified CBN products are being sold as ... by the University of Sydney Animal Ethics Committee and were in accordance with the Australian Code of Practice for the Care ...

Human trials are now under way ... Sydney has identified a constituent in the cannabis plant that improves sleep. Their ...

A Winnipeg bylaw to crack down on large medical marijuana grow-ops seems to be working. In 2022, the City of Winnipeg passed ...

MIPLYFFA was further granted Orphan Medicinal Product designation by the European Medicines Agency (EMA) for the treatment of NPC. MIPLYFFA is indicated for use ... committee; statements or decisions ...

According to the WHO, about 40 percent of pharmaceutical products are based on natural sources, and 70 percent of people ...